UBA1 and cutaneous squamous cell carcinoma: Previous studies have associated abnormal UBA1 expression with the progression of hepatocellular carcinoma (HCC), small-cell lung cancer (SCLC), and cutaneous squamous cell carcinoma (SCC) [27,28,29].